Summary of Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2020

Investments, All Other Investments [Abstract]

Schedule of Financial Assets and Liabilities Measured and Not Measured at Fair Value

Certain of our financial instruments are not measured at fair value on a recurring basis. The estimates presented are not necessarily indicative of the amounts at which these instruments could be purchased, sold or settled. The carrying amounts and estimated fair values of financial instruments were as follows (in thousands):

	September 30, 2020				December 31, 2019
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Financial assets measured at fair value:
Restricted investment	$	156	$	156	$	1,195	$	1,195
Financial liabilities measured at fair value:
Deferred compensation plan	$	1,156	$	1,156	$	4,729	$	4,729
Contingent consideration	2,359		2,359		5,627		5,627
Financial assets not measured at fair value:
Cash and cash equivalents	$	68,623	$	68,623	$	35,349	$	35,349
Restricted cash	36,577		36,577		17,900		17,900
Accounts receivable, net	3,833		3,833		7,241		7,241
Due from affiliates	108		108		357		357
Due from Ashford Trust	2,585		2,585		4,805		4,805
Due from Braemar	124		124		1,591		1,591
Investments in unconsolidated entities	3,777		3,777		3,476		3,476
Financial liabilities not measured at fair value:
Accounts payable and accrued expenses	$	42,093	$	42,093	$	39,160	$	39,160
Dividends payable	15,860		15,860		4,725		4,725
Due to affiliates	733		733		1,011		1,011
Other liabilities	31,664		31,664		13,868		13,868
Notes payable	62,790		59,109 to 65,331		36,810		34,705 to 38,359